Market Tracker

08/18 5:16pm ET

Cytokinetics Inc (NASDAQ:CYTK)

12.50
Delayed Data
As of Aug 18
 +0.05 / +0.40%
Today’s Change
8.51
Today|||52-Week Range
17.20
+2.88%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close12.45
Today’s open12.35
Day’s range12.30 - 12.70
Volume930,981
Average volume (3 months)697,960
Market cap$670.8M
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-652.38%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+271.30%
P/E ratioNM
Price/Sales4.86
Price/Book5.38

Competitors

 Today’s
change
Today’s
% change
INSYINSYS Therapeutics I...-0.11-1.19%
DOVADova Pharmaceuticals...+0.17+0.66%
RETAReata Pharmaceutical...-0.14-0.53%
SGYPSynergy Pharmaceutic...+0.01+0.34%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)-$0.61
Annual revenue (last year)$106.4M
Annual profit (last year)$16.5M
Net profit margin15.46%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer &
Senior Vice President
Ching Jaw
Corporate headquarters
South San Francisco, California

Forecasts